Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity.
Rutten L, Swart M, Koornneef A, Bouchier P, Blokland S, Sadi A, Juraszek J, Vijayan A, Schmit-Tillemans S, Verspuij J, Choi Y, Daal CE, Perkasa A, Torres Morales S, Myeni SK, Kikkert M, Tolboom J, van Manen D, Kuipers H, Schuitemaker H, Zahn R, Langedijk JPM.
Rutten L, et al. Among authors: langedijk jpm.
Sci Rep. 2024 Mar 8;14(1):5735. doi: 10.1038/s41598-024-56293-x.
Sci Rep. 2024.
PMID: 38459086
Free PMC article.